Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice

Journal of the American Society of Hypertension

Volumn 3, Issue 3, 2009, Pages 221-227

  Mulazzi, Isabelle ^a   Cambou, Jean Pierre ^b   Girerd, Xavier ^c   Nicodeme, Robert ^a   Chamontin, Bernard ^a,b   Amar, Jacques ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adherence; cardiovascular; control; secondary prevention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; ALCOHOL CONSUMPTION; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENDER; GENERAL PRACTICE; GENERAL PRACTITIONER; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STROKE; WAITING ROOM;

EID: 67349159852     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.12.004     Document Type: Article

References (30)

1. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
2. Shankar A., Wang J.J., Rochtchina E., and Mitchell P. Positive association between plasma fibrinogen level and incident hypertension among men. Population-based cohort study. Hypertension 48 (2006) 1043-1049
3. Amar J., Vaur L., Perret M., Bailleau C., Etienne S., and Chamontin B. PRATIK Study Investigators. Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK Study). J Hypertens 20 (2002) 779-784
4. Amar J., Chamontin B., Genes N., Cantet C., Salvador M., and Cambou J.P. Why is hypertension so frequently uncontrolled in secondary prevention?. J Hypertens 21 (2003) 1199-1205
5. Amar J., Chamontin B., Ferrieres J., Danchin N., Grenier O., Cantet C., et al. Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis-the PREVENIR Study. Heart 88 (2002) 587-591
6. Amar J, Cambou JP, Quentzel S, Amelineau E, Danchin N. Controlled diastolic blood pressure, previous stroke and associated risk factors are obstacles to improving systolic blood pressure. J Hum Hypertens. Forthcoming.
7. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22 (2001) 554-572
8. Caro J.J., Salas M., Speckman J.L., Raggio G., and Jackson J.D. Persistence with treatment for hypertension in actual practice. CMAJ 160 (1999) 31-37
9. Setaro J.F., and Black H.R. Refractory hypertension. N Engl J Med 327 (1992) 543-546
10. Yakovlevitch M., and Black H.R. Resistant hypertension in a tertiary care clinic. Arch Intern Med 151 (1991) 1786-1792
11. DiMatteo M.R., Giordani P.J., Lepper H.S., and Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40 (2002) 794-811
12. Stewart M. The validity of an interview to assess a patient's drug taking. Am J Prev Med 3 (1987) 95-100
13. Kruse W., and Weber E. Dynamics of drug regimen compliance. Its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 38 (1990) 561-565
14. Mallion J.M., Meilhac B., Tremel F., Calvez R., and Bertholom N. Use of a microprocessor-equipped tablet box in monitoring compliance with antihypertensive treatment. J Cardiovasc Pharmacol 19 (1992) S41-S48
15. Vaur L., Vaisse B., Genes N., Elrik F., Legrand C., and Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance. Results of a large-scale trial. Am J Hypertens 12 (1999) 374-380
16. Waeber B., Burnier M., and Brunner H.R. Compliance with antihypertensive therapy. Clin Exp Hypertens 21 (1999) 973-985
17. Girerd X., Radauceanu A., Achard J.M., Fourcade J., Tournier B., Brillet G., et al. The compliance evaluation test: a validated tool for detection of nonadherence among hypertensive treated patients. Arch Mal Cœur 94 (2001) 839-842
18. Girerd X., Hanon O., Anagnostopoulos K., Ciupek C., Mourad J.J., and Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Presse Med 30 (2001) 1044-1048
19. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 19 (2006) 1190-1196
20. Burnier M., Santschi V., Favrat B., and Brunner H.R. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl 21 (2003) S37-S42
21. Burnier M., Schneider M.P., Chiolero A., Stubi C.L., and Brunner H.R. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 19 (2001) 335-341
22. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986) 67-74
23. Fuchs F.D., Chambless L.E., Whelton P.K., Nieto F.J., and Heiss G. Alcohol consumption and the incidence of hypertension: the Atherosclerosis Risk in Communities Study. Hypertension 37 (2001) 1242-1250
24. MacMahon S.W., Blacket R.B., Macdonald G.J., and Hall W. Obesity, alcohol consumption and blood pressure in Australian men and women: the National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens 2 (1984) 85-91
25. Marques-Vidal P., Arveiler D., Evans A., Amouyel P., Ferrieres J., and Ducimetiere P. Different alcohol drinking and blood pressure relationships in France and Northern Ireland: the PRIME Study. Hypertension 38 (2001) 1361-1366
26. Grote L., Hedner J., and Peter J.H. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 18 (2000) 679-685
27. Schrier R.W. Treating high-risk diabetic hypertensive patients with comorbid conditions. Am J Kidney Dis 36 (2000) S10-S17
28. Franklin S.S., Gustin IV W., Wong N.D., Larson M.G., Weber M.A., Kannel W.B., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96 (1997) 308-315
29. Amar J., Ruidavets J.B., Chamontin B., Drouet L., and Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 19 (2001) 381-387
30. Blacher J., Asmar R., Djane S., London G.M., and Safar M.E. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33 (1999) 1111-1117